Efficacy and Safety of MCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
Clinical trial NCT04945772 · COMPLETED
Trial details
- NCT number
- NCT04945772
- Sponsor
- Nanoscope Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-13
- Primary completion
- 2023-02-27
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.